Oncology News

Chemotherapy-induced changes to the gut microbiome may explain why some patients with cancer experience post-chemotherapy cognitive decline.

The addition of an investigational immunotherapy to chemotherapy prolonged survival for women with advanced ovarian cancer, according to a topline data announcement.

From 2007 to 2020, the incidence of cervical intraepithelial neoplasia grades 1, 2 and 3 continuously decreased among women aged 15 to 25 years while increasing among women aged 25 to 29 years, researchers reported.

Women with unilateral breast cancer who underwent bilateral mastectomy had a significantly lower risk for contralateral breast cancer than those who underwent other surgical procedures, results of a cohort study showed.

Informing patients of the benefit-harm balance associated with mammography screening is beneficial and did not hinder overall screening decisions, according to results of a national probability-based U.S. survey.

Women treated for breast cancer exhibited highly prevalent and distressing sexual health concerns, according to results of the WISH-BREAST study presented at ASCO Annual Meeting.

Women who undergo allogeneic hematopoietic cell transplantation can get pregnant and have healthy children, according to results of a retrospective study conducted in Germany.

Elizabeth A. Comen, MD, has been appointed associate professor in the department of medicine at NYU Langone Health’s Perlmutter Cancer Center.

About 40% of cancer cases and nearly half of cancer deaths among U.S. adults aged 30 years or older can be attributable to modifiable risk factors, according to a study led by American Cancer Society researchers.

CHICAGO — The addition of abemaciclib to fulvestrant extended PFS for patients with advanced breast cancer whose disease progressed on prior cyclin-dependent kinase 4/6 inhibitor therapy, according to data presented at ASCO Annual Meeting.